A Unique Virtual Environment where Healthcare Professionals Can Find the Support that They Need for an Adequate Use of Pharmaceutical Products

Projektinformationen

DOCTRINA

ID Finanzhilfevereinbarung: 773732

DOI

10.3030/773732

Projekt abgeschlossen

EK-Unterschriftsdatum 1 Mai 2017

Startdatum 1 Mai 2017

Enddatum 31 August 2017

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten

€ 71 429,00

EU-Beitrag

€ 50 000,00

Koordiniert durch

DOCTRINA, IZOBRAZEVANJE, DOO
Slovenia

Periodic Reporting for period 1 - DOCTRINA (A Unique Virtual Environment where Healthcare Professionals Can Find the Support that They Need for an Adequate Use of Pharmaceutical Products)

Berichtszeitraum: 2017-05-01 bis 2017-08-31

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

DOCTRINA is a new market-oriented ICT solution built as a virtual open space for further education, barrier-free communication and sharing between users. Our platform is built on a novel and cost-efficient model, and has been validated in 4 countries where pharmaceutical companies and healthcare professionals form a global network of over 40000 pharmacies and over 50 pharmaceutical companies.
Pharmaceutical companies need to guarantee the support and further training of prescribing doctors and dispensing pharmacists, to promote a more rational use of medicines and healthcare expenditure. DOCTRINA supports this global community of users, disrupting the way pharmaceutical providers communicate with healthcare givers. Our solution allows for direct target-based communication between these two groups of professionals. It is especially designed to respond to today’s challenges faced by the healthcare industry when dealing with the use of pharmaceutical products.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

During the feasibility period we have prepared an optimization plan based on improving DOCTRINA’s functionalities for 3 types of users.
We have identified risks and the selected contingency measures.
We have conducted a market analysis to confirm the market potential and a favorable horizon for DOCTRINA.
We have performed an in depth FTO analysis and we have confirmed that there are no direct competitors for DOCTRINA.
We have validated our financial projections and growth strategy.
We have prepared a business plan supported by the feasibility of the project.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

The current model is based on support through sales representatives. However, this system is not effective, due to the lack of time of healthcare professionals for commercial visits, the lack of global systems that give access to many products at a time, and the lack of useful education on specific products. Not only are doctors and pharmacists increasingly reluctant to visits by pharmaceutical sales representatives but these also filter doctors whom they want to visit. This inadequate support to drug prescribers and dispensers results in costly market launch of new products, low adoption and their incorrect use.
DOCTRINA will enable pharmaceutical companies to drive their business more efficiently, while offering better support related to pharmaceutical products. The practice of healthcare professionals will improve, thanks to this emphasis on open source information, education and training that will lead to better adherence to medicines by patients.

image-1.png